EORTC risk tables - A new diagnostic tool in urology;Tabele ryzyka EORTC - Nowe narzȩdzie diagnostyczne w urologii

Polski Merkuriusz Lekarski

Volumn 27, Issue 162, 2009, Pages 524-528

  Bobiński, Jarosław ^a   Lipiński, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

EORTC risk tables; Nomograms; Non muscle invasive bladder cancer; Risk factors; Risk groups

Indexed keywords

BLADDER TUMOR; CANCER STAGING; CARCINOMA IN SITU; CLASSIFICATION; DISEASE COURSE; HUMAN; PATHOLOGY; REVIEW; RISK FACTOR; TUMOR RECURRENCE;

CARCINOMA IN SITU; DISEASE PROGRESSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 74049105533     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Heney N.M., Arnried S., Flangan M. J. i wsp.: (for National Cancer Collaborative Group A) Superficial bladder cancer. Progression and recurrence. J. Ural., 1983, 130, 1083-1086.
2. Wojciechowska U., Didkowska J., Tarnowski W. i wsp.: Nowotwory złośliwe w Polsce w 2002 roku, Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warszawa, 2004, 15-95.
3. Allard P., Bernard P., Fradet Y. i wsp.: The early clinical course of primary Ta and T1 bladder cancer, a proposed prognostic index. Br. J. Urol., 1998, 81, 692-698.
4. Kurth K. H., Denis L, Bouffioux C. i wsp.: Factors affecting recurrence and progression in superficial bladder tumors. Eur. J. Cancer., 1995, 31A, 1840-1846.
5. Edward M.: Urothelial Tumors of the Bladder. In: Cambell-Walsh Urology. Wein A.J.(red). Saunders Elsevier, Philadelphia, 2007, 2407-2447.
6. Takashi M., Murase T., Mizuno S. i wsp.: Multivariate evaluation of prognostic determinants in bladder cancer patients. J. Urol., 1989, 141, 22-26.
7. Parmar M.K.B., Freedman L.S., Hargreave T.B. i wsp.: Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J. Urol., 1989, 142, 284-288.
8. Fradet Y.: Prognostic factors: back to the future. In: Superficial Bladder Cancer. Pagano F. (red). ISIS Medical Media, Oxford, 1997, 57-70.
9. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J. I wsp.: Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J. Urol., 2000, 164, 680-684.
10. Oostertinck W., Lobel B., Jakse G. I wsp.: Guidelines on bladder cancer. EUA Guidelines, 2001.
11. Sylvester R. J., van der Meijden A.P.M., Oosterlinck W. i wsp.: Predicting recurrence in individual patients with Stage Ta, T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur. J. Urol., 2006, 49, 466-477.
12. Sylvester R.J., van der Meijden A.P.M., Lamm D.: Intravesical Bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer, a combined analysis of the published results of randomized clinical trials. J. Urol., 2002, 168, 1964-1970.
13. Bohle A., Jocham D., Bock P.R.: Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J. Urol., 2003, 269, 90-95.
14. Mian Ch., Pycha A.: Risk stratification in superficial bladder cancer: fact or fiction. Eur. Urol., 2007, EAU-EBU Update series 5, 63-69.
15. Shariati S.F., Casella R., Monoski M.A. i wsp.: The addition of urinary urokinase - type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer. J. Urol., 2003, 170, 2244-2247.
16. Herr H.: The value of second transurethral resection In evaluating patients with bladder tumors. J. Urol., 1999, 162, 74-76.
17. Bol M.G., Baak J. P., Buhr-Wildhagen S. i wsp.: Reproducibility and prognostic variability of grade and lamina propria Invasion in stage Ta, T1 urothelial carcinoma of the bladder. J. Urol., 2003, 169, 1291-1294.
18. Zaak D., Hungerhuber E., Schneede P.: Role of 5-aminolevulinic acid in detection of urothelial premalignant lesions. Cancer, 2002, 95, 1234-1238.
19. Lopez-Beltran A., Cheng L.: Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology, 2003, 35, 484-491.